WeVote
Log In

Bill

Bill

H 2500

An Act relative to increasing access to epinephrine

194th Legislature (2025-2026) Introduced by James Arena-DeRosa and 19 co-sponsors

Massachusetts bill expanding epinephrine access in schools and public spaces to prevent deaths from severe allergic reactions.

Accompanied a new draft, see H4607
0
WeVote Research Nonpartisan
Bill Summary · H 2500

Legislative bill overview

H 2500 seeks to expand access to epinephrine auto-injectors (EpiPens) in Massachusetts by removing barriers to procurement and distribution. The bill addresses availability in schools, public spaces, and for at-risk individuals who may not have prescriptions or the ability to carry their own devices.

Why is this important

Epinephrine is the first-line emergency treatment for severe allergic reactions (anaphylaxis), which can be fatal within minutes. Increased access in public settings and among vulnerable populations could prevent deaths and serious health outcomes, particularly in children and individuals with undiagnosed or severe allergies.

Potential points of contention

  • Liability concerns: Schools and public venues may hesitate to stock and administer epinephrine without clear liability protections, though "Good Samaritan" laws typically shield those acting in good faith during emergencies
  • Cost and funding: Expanding epinephrine availability requires funding for procurement and staff training; unclear who bears these costs (state, municipalities, private institutions)
  • Standing prescriptions vs. standing orders: Debate exists over whether epinephrine should require individual prescriptions or be available via standing orders (pre-authorization by physicians for broader use)

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.